Company / SG&A per Share
TherapeuticsMD, Inc. SG&A per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.77
FY2024
5-year range
$0.20 / $9.39
FY2020-FY2024
Trend
-87.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.12 in FY2016 to $9.39 in FY2022.
Based on SEC 10-K filings.
0.77 in FY2024 with a 5-year CAGR of +26.3%.
Improved from $9.39 to $0.77 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +56.4%
- 5-Year CAGR
- +26.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, sg&a per share decreased 87.1% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.77 | -87.1% |
| FY2023 | $5.97 | -36.4% |
| FY2022 | $9.39 | +4553.7% |
| FY2021 | $0.20 | -52.8% |
| FY2020 | $0.43 | +78.2% |
| FY2019 | $0.24 | +1.1% |
| FY2018 | $0.24 | +62.5% |
| FY2017 | $0.15 | +17.4% |
| FY2016 | $0.12 | -5.2% |
| FY2015 | $0.13 | +35.1% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026